Chemkart India Limited has made a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 (Regulation 30) regarding an investment in its wholly-owned subsidiary.

Investment Details

  • Investment Amount: ₹1.00 Crore
  • Investment Method: Rights Issue
  • Shares Allotted: 10,00,000 Equity Shares
  • Face Value: ₹10 per share
  • Issue Price: ₹10 per share (at face value)
  • Consideration Type: Cash
  • Total Consideration: ₹1.00 Crore

Subsidiary Company Details

  • Name: Easy Raw Materials Private Limited
  • Status: Wholly Owned Subsidiary
  • Authorized Share Capital: ₹10,00,00,000 (Ten Crores) divided into 1,00,00,000 Equity Shares of ₹10 each
  • Paid-up Share Capital (Post-allotment): ₹7,51,00,000 (Seven Crores Fifty-One Lakh) divided into 75,10,000 Equity Shares of ₹10 each
  • Industry: Trading of Pharma Products and Nutritional Supplements
  • Country of Incorporation: India
  • Date of Incorporation: 2020

Financial Performance of Subsidiary (as of 31st March 2026)

  • Turnover: NIL
  • Loss After Tax: ₹59.47 Lakh
  • Net Worth: ₹578.60 Lakh
  • Last 3 Years Turnover: NIL

Shareholding Pattern

  • Pre-allotment Shareholding: 100.00%
  • Post-allotment Shareholding: 100.00%

Purpose of Investment

The investment is part of the utilization of IPO proceeds towards commissioning of the manufacturing unit of the subsidiary company.